Cancer BiologybioRxiv
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia
F. Brown, E. Still, P. Cifani…·A. Kentsis
This study identifies MEF2C phosphorylation as a marker of chemotherapy resistance in AML and shows that inhibiting this phosphorylation can overcome resistance in MEF2C-activated cells.
DOI 10.1158/2159-8290.cd-17-1271